These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14682406)

  • 21. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children].
    Yoshida Y; Inoue T; Nishikido T; Kameda M; Takamatu I; Doi S
    Arerugi; 2007 Dec; 56(12):1502-9. PubMed ID: 18195554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled beclomethasone versus placebo for chronic asthma.
    Adams NP; Bestall JB; Malouf R; Lasserson TJ; Jones PW
    Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD002738. PubMed ID: 15674896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A; Richter A; Oster H; Criée CP
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
    Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
    J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP; Harrison LI
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
    Bousquet J; Cantini L
    Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
    Thongngarm T; Silkoff PE; Kossack WS; Nelson HS
    J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA-134a) is equivalent to BDP-CFC for the treatment of asthma: Milanowski et al. (Respir Med 1999; 93: 245-251).
    Ayres JG
    Respir Med; 2000 Feb; 94(2):181-2; author reply 183. PubMed ID: 10714430
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography.
    Goldin JG; Tashkin DP; Kleerup EC; Greaser LE; Haywood UM; Sayre JW; Simmons MD; Suttorp M; Colice GL; Vanden Burgt JA; Aberle DR
    J Allergy Clin Immunol; 1999 Dec; 104(6):S258-67. PubMed ID: 10588987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
    Nayak A; Lanier R; Weinstein S; Stampone P; Welch M
    Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
    Aubier M; Wettenger R; Gans SJ
    Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate.
    Juniper EF; Price DB; Stampone PA; Creemers JP; Mol SJ; Fireman P
    Chest; 2002 Jun; 121(6):1824-32. PubMed ID: 12065345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
    Leach CL; Davidson PJ; Boudreau RJ
    Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
    Ederle K;
    Eur Rev Med Pharmacol Sci; 2003; 7(2):45-55. PubMed ID: 12911119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.